Division of Biological Systems and Engineering, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Methods Mol Biol. 2023;2701:77-90. doi: 10.1007/978-1-0716-3373-1_5.
Many chemicals cause mutation or cancer in animals and humans by forming DNA lesions, including base adducts, which play a critical role in mutagenesis and carcinogenesis. A large number of such adducts are repaired by the DNA glycosylase-mediated base excision repair (BER) pathway, and some are processed by nucleotide excision repair (NER) and nucleotide incision repair (NIR). To understand what structural features determine repair enzyme specificity and mechanism in chemically modified DNA in vitro, we developed and optimized a DNA cleavage assay using defined oligonucleotides containing a single, site specifically placed lesion. This assay can be used to investigate novel activities against any newly identified derivatives from chemical compounds, substrate specificity and cleavage efficiency of repair enzymes, and quantitative structure-function relationships. Overall, the methodology is highly sensitive and can also be modified to explore whether a lesion is processed by NER or NIR activity, as well as to study its miscoding properties in translesion DNA synthesis (TLS).
许多化学物质通过形成 DNA 损伤,包括碱基加合物,在动物和人类中引起突变或癌症,在突变和致癌中起着关键作用。大量这样的加合物通过 DNA 糖苷酶介导的碱基切除修复 (BER) 途径修复,一些通过核苷酸切除修复 (NER) 和核苷酸切口修复 (NIR) 处理。为了了解什么结构特征决定了体外化学修饰 DNA 中修复酶的特异性和机制,我们开发并优化了一种使用含有单个、定点放置损伤的特定寡核苷酸的 DNA 切割测定法。该测定法可用于研究针对任何新鉴定的化学化合物衍生物的新型活性、修复酶的底物特异性和切割效率,以及定量构效关系。总的来说,该方法非常灵敏,也可以进行修改,以探索损伤是否通过 NER 或 NIR 活性进行处理,以及研究其在跨损伤 DNA 合成 (TLS) 中的错配特性。